Avotres
Cedar Knolls
About Avotres
Avotres is a biotechnology company that is developing novel therapeutics for incurable immunologically mediated diseases. In these therapeutic areas with significant unmet medical needs, they use cutting-edge science to uncover potentially paradigm-shifting immunological pathways in they improving the lives of millions of patients. AVT002, a monoclonal antibody, is also being developed as a potential cancer therapy directed at a novel immuno-oncology target.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.0M
- Funding stage: Seed
- Last round: Debt Financing (May 2023)
- Website: avotres.com
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/avotres-8124 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.